A Multi-Center, Randomized, Blinded, Active [zolpidem; Ambien CR] and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs

Trial Profile

A Multi-Center, Randomized, Blinded, Active [zolpidem; Ambien CR] and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2008

At a glance

  • Drugs Adipiplon; Zolpidem
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Neurogen Corporation
  • Most Recent Events

    • 16 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top